Search research articles
Contact Us
Filters
Showing results (21-30 of 93) with videos related to
Page
of 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1996
Influence of age on the treatment of limited-stage small-cell lung cancer
L L Siu, F A Shepherd, N Murray, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review
L Khoja, D Day, T Wei-Wu Chen, et al.
ESMO Open
|
July 15, 2025
The use of machine learning models to predict progression-free survival and overall survival outcomes from waterfall plots in randomized clinical trials (MAP-OUTCOMES)
K Alshankati, A Alshibany, A Toma, et al.
European Journal of Cancer Care
|
June 26, 2007
A comparison of patient adherence and preference of packaging method for oral anticancer agents using conventional pill bottles versus daily pill boxes
P W Macintosh, G R Pond, B J Pond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2014
Prioritizing targets for precision cancer medicine
F Andre, E Mardis, M Salm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 22, 2018
Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
M Oliva, A Spreafico, M Taberna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2015
A systematic review of immune-related adverse event reporting in clinical trials of immune checkpoint inhibitors
T W Chen, A R Razak, P L Bedard, et al.
Oral Oncology
|
August 9, 2002
A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma
J S McCarthy, I F Tannock, P Degendorfer, et al.
The American Journal of Pathology
|
December 7, 2000
Consistent patterns of allelic loss in natural killer cell lymphoma
L L Siu, V Chan, J K Chan, et al.
Cancer Genetics and Cytogenetics
|
September 22, 2001
Chronic T-cell lymphoproliferative disease expressing natural killer cell receptors: clinicopathological and molecular features
Y L Kwong, C C Lam, C Choy, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 93) with videos related to
Sort By:
Page
of 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1996
Influence of age on the treatment of limited-stage small-cell lung cancer
L L Siu, F A Shepherd, N Murray, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review
L Khoja, D Day, T Wei-Wu Chen, et al.
ESMO Open
|
July 15, 2025
The use of machine learning models to predict progression-free survival and overall survival outcomes from waterfall plots in randomized clinical trials (MAP-OUTCOMES)
K Alshankati, A Alshibany, A Toma, et al.
European Journal of Cancer Care
|
June 26, 2007
A comparison of patient adherence and preference of packaging method for oral anticancer agents using conventional pill bottles versus daily pill boxes
P W Macintosh, G R Pond, B J Pond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2014
Prioritizing targets for precision cancer medicine
F Andre, E Mardis, M Salm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 22, 2018
Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
M Oliva, A Spreafico, M Taberna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2015
A systematic review of immune-related adverse event reporting in clinical trials of immune checkpoint inhibitors
T W Chen, A R Razak, P L Bedard, et al.
Oral Oncology
|
August 9, 2002
A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma
J S McCarthy, I F Tannock, P Degendorfer, et al.
The American Journal of Pathology
|
December 7, 2000
Consistent patterns of allelic loss in natural killer cell lymphoma
L L Siu, V Chan, J K Chan, et al.
Cancer Genetics and Cytogenetics
|
September 22, 2001
Chronic T-cell lymphoproliferative disease expressing natural killer cell receptors: clinicopathological and molecular features
Y L Kwong, C C Lam, C Choy, et al.
Page
of 10